HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
A John Iafrate Selected Research
A John Iafrate Research Topics
Disease
125
Neoplasms (Cancer)
02/2024 - 12/2006
29
Lung Neoplasms (Lung Cancer)
01/2019 - 05/2008
18
Glioma (Gliomas)
01/2019 - 12/2006
16
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 05/2008
14
Glioblastoma (Glioblastoma Multiforme)
11/2021 - 04/2007
12
Breast Neoplasms (Breast Cancer)
11/2023 - 11/2011
10
Adenocarcinoma of Lung
12/2017 - 07/2007
8
COVID-19
03/2024 - 10/2020
8
Infections
12/2022 - 07/2020
8
Brain Neoplasms (Brain Tumor)
01/2021 - 07/2009
8
Neoplasm Metastasis (Metastasis)
01/2021 - 07/2011
7
Disease Progression
07/2023 - 10/2012
7
Cholangiocarcinoma
01/2023 - 01/2012
6
Carcinoma (Carcinomatosis)
01/2022 - 05/2007
5
Sarcoma (Soft Tissue Sarcoma)
11/2020 - 05/2009
5
Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 04/2010
4
Circulating Neoplastic Cells
08/2023 - 07/2008
3
Melanoma (Melanoma, Malignant)
01/2023 - 01/2012
3
Lymphopenia (Lymphocytopenia)
01/2021 - 11/2011
3
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2020 - 01/2012
3
Astrocytoma (Pilocytic Astrocytoma)
01/2019 - 12/2006
3
Oligodendroglioma
01/2019 - 12/2006
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2015 - 11/2011
3
Adenocarcinoma
12/2011 - 07/2007
2
Hyperglycemia
07/2023 - 11/2011
2
Meningioma (Meningiomas)
01/2023 - 11/2018
2
Eosinophilia
01/2022 - 11/2020
2
Lymphoma (Lymphomas)
01/2021 - 05/2011
2
Thyroid Neoplasms (Thyroid Cancer)
01/2018 - 12/2014
2
Pancreatic Cyst
01/2017 - 01/2016
2
Mucinous Adenocarcinoma (Mucinous Carcinoma)
08/2015 - 07/2007
2
Neuroblastoma
02/2015 - 05/2008
2
Microsatellite Instability
09/2014 - 04/2010
Drug/Important Bio-Agent (IBA)
19
Crizotinib
IBA
01/2017 - 10/2010
18
DNA (Deoxyribonucleic Acid)
IBA
02/2024 - 02/2007
17
Phosphotransferases (Kinase)
IBA
11/2021 - 12/2007
16
Proteins (Proteins, Gene)
FDA Link
03/2024 - 04/2007
16
ErbB Receptors (EGF Receptor)
IBA
01/2019 - 05/2007
14
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
11/2021 - 02/2011
14
Anaplastic Lymphoma Kinase
IBA
10/2016 - 05/2008
13
RNA (Ribonucleic Acid)
IBA
04/2022 - 03/2010
12
Tyrosine Kinase Inhibitors
IBA
01/2019 - 07/2007
10
Biomarkers (Surrogate Marker)
IBA
02/2024 - 02/2011
10
Antibodies
IBA
11/2023 - 07/2008
6
Vaccines
IBA
11/2023 - 10/2021
6
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
11/2021 - 05/2008
6
Cell-Free Nucleic Acids
IBA
01/2021 - 01/2017
6
alpha-hydroxyglutarate
IBA
01/2018 - 11/2012
5
Hormones (Hormone)
IBA
08/2023 - 01/2017
5
Paraffin
IBA
01/2022 - 10/2007
5
Codon (Codons)
IBA
12/2017 - 07/2007
4
Estrogen Receptors
IBA
08/2023 - 07/2014
4
COVID-19 Vaccines
IBA
01/2023 - 01/2022
4
Formaldehyde (Formol)
FDA Link
01/2022 - 01/2011
4
Circulating Tumor DNA
IBA
01/2022 - 12/2015
4
tyrosine receptor (receptor, tyrosine)
IBA
11/2021 - 12/2011
4
Enzymes
IBA
10/2020 - 01/2012
4
Nucleotides
IBA
11/2019 - 01/2011
4
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2019 - 01/2008
4
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2017 - 05/2007
3
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
07/2023 - 11/2010
3
BNT162 Vaccine
IBA
01/2022 - 10/2021
3
Immunoglobulin G (IgG)
IBA
11/2020 - 10/2020
3
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2019 - 12/2014
3
Temozolomide (Temodar)
FDA Link
Generic
01/2017 - 04/2007
2
Fulvestrant (Faslodex)
FDA Link
08/2023 - 11/2019
2
Imatinib Mesylate (Gleevec)
FDA Link
01/2022 - 11/2020
2
palbociclib
IBA
01/2021 - 11/2019
2
Immunoglobulin M (IgM)
IBA
11/2020 - 10/2020
2
Chromatin
IBA
11/2020 - 01/2011
2
Carrier Proteins (Binding Protein)
IBA
11/2020 - 01/2017
2
Guanine Nucleotides
IBA
11/2020 - 01/2017
2
Neutralizing Antibodies
IBA
10/2020 - 10/2020
2
Tumor Biomarkers (Tumor Markers)
IBA
01/2020 - 11/2011
2
dacomitinib
IBA
01/2020 - 01/2019
2
Progesterone Receptors (Progesterone Receptor)
IBA
11/2019 - 01/2018
2
Everolimus
FDA Link
11/2019 - 11/2011
2
CH5183284
IBA
01/2019 - 01/2019
2
Methyltransferases
IBA
01/2019 - 01/2008
2
Ligands
IBA
01/2019 - 05/2009
2
infigratinib
IBA
01/2019 - 01/2017
2
lorlatinib
IBA
01/2018 - 01/2016
2
Nicotinamide Phosphoribosyltransferase
IBA
01/2018 - 12/2015
2
Keratins (Keratin)
IBA
06/2017 - 12/2015
2
Coenzymes (Enzyme Cofactors)
IBA
01/2017 - 12/2015
2
Carcinoembryonic Antigen
IBA
01/2017 - 01/2016
2
alectinib
IBA
10/2016 - 11/2014
2
B7-H1 Antigen
IBA
01/2016 - 03/2015
2
Messenger RNA (mRNA)
IBA
01/2016 - 01/2014
2
Adenosine Monophosphate (AMP)
IBA
11/2015 - 12/2014
2
human ERBB2 protein
IBA
02/2015 - 08/2013
2
Catenins
IBA
01/2013 - 09/2011
2
Alanine Transaminase (SGPT)
IBA
10/2012 - 11/2011
2
Complement System Proteins (Complement)
IBA
01/2012 - 07/2011
Therapy/Procedure
81
Therapeutics
11/2023 - 01/2008
7
Drug Therapy (Chemotherapy)
01/2019 - 05/2008
5
Precision Medicine
11/2023 - 04/2016
5
Radiotherapy
07/2023 - 04/2007
2
Transplantation
01/2019 - 02/2009
2
Lab-On-A-Chip Devices
11/2014 - 07/2008